
### [NCIT:C96498](http://purl.obolibrary.org/obo/NCIT_C96498)
**Label:** Colorectal Lymphoma

**Subclasses:** [NCIT:C27465](http://purl.obolibrary.org/obo/NCIT_C27465) (Colon Burkitt Lymphoma), [NCIT:C5515](http://purl.obolibrary.org/obo/NCIT_C5515) (Cecum Lymphoma), [NCIT:C27411](http://purl.obolibrary.org/obo/NCIT_C27411) (Colon Mantle Cell Lymphoma), [NCIT:C5499](http://purl.obolibrary.org/obo/NCIT_C5499) (Colon Hodgkin Lymphoma), [NCIT:C5521](http://purl.obolibrary.org/obo/NCIT_C5521) (Cecum Non-Hodgkin Lymphoma), [NCIT:C4950](http://purl.obolibrary.org/obo/NCIT_C4950) (Colon Non-Hodgkin Lymphoma), [NCIT:C96499](http://purl.obolibrary.org/obo/NCIT_C96499) (Colorectal Non-Hodgkin Lymphoma), [NCIT:C96500](http://purl.obolibrary.org/obo/NCIT_C96500) (Colorectal Hodgkin Lymphoma), [NCIT:C4793](http://purl.obolibrary.org/obo/NCIT_C4793) (Colon Lymphoma), [NCIT:C5553](http://purl.obolibrary.org/obo/NCIT_C5553) (Rectal Lymphoma), [NCIT:C5498](http://purl.obolibrary.org/obo/NCIT_C5498) (Colon Mucosa-Associated Lymphoid Tissue Lymphoma), [NCIT:C96501](http://purl.obolibrary.org/obo/NCIT_C96501) (Colorectal High Grade B-Cell Lymphoma, Not Otherwise Specified), [NCIT:C96502](http://purl.obolibrary.org/obo/NCIT_C96502) (Colorectal Burkitt Lymphoma), [NCIT:C96503](http://purl.obolibrary.org/obo/NCIT_C96503) (Colorectal Diffuse Large B-Cell Lymphoma), [NCIT:C96504](http://purl.obolibrary.org/obo/NCIT_C96504) (Colon Diffuse Large B-Cell Lymphoma), [NCIT:C96505](http://purl.obolibrary.org/obo/NCIT_C96505) (Colorectal Mantle Cell Lymphoma), [NCIT:C96506](http://purl.obolibrary.org/obo/NCIT_C96506) (Colorectal Mucosa-Associated Lymphoid Tissue Lymphoma), 

**Class expressions from DL-Learner:**

- Thing 52.89%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) 39.20%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C3994](http://purl.obolibrary.org/obo/NCIT_C3994) (Stage IV Colon Cancer AJCC v6))) 39.20%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C3993](http://purl.obolibrary.org/obo/NCIT_C3993) (Stage II Colon Cancer AJCC v6))) 39.20%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39914](http://purl.obolibrary.org/obo/NCIT_C39914) (Gain of Chromosome 12p))) 39.20%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C3991](http://purl.obolibrary.org/obo/NCIT_C3991) (Thrombocytopenia Due to Immune Destruction))) 39.20%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39909](http://purl.obolibrary.org/obo/NCIT_C39909) (Gain of Chromosome 18q))) 39.20%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39907](http://purl.obolibrary.org/obo/NCIT_C39907) (Seminal Vesicle Cystadenoma))) 39.20%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39906](http://purl.obolibrary.org/obo/NCIT_C39906) (Seminal Vesicle Adenocarcinoma))) 39.20%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39905](http://purl.obolibrary.org/obo/NCIT_C39905) (Prostate Stromal Proliferation of Uncertain Malignant Potential))) 39.20%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39903](http://purl.obolibrary.org/obo/NCIT_C39903) (Prostate Adenocarcinoma with Focal Neuroendocrine Differentiation))) 39.20%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39902](http://purl.obolibrary.org/obo/NCIT_C39902) (Prostate Basal Cell Carcinoma))) 39.20%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39901](http://purl.obolibrary.org/obo/NCIT_C39901) (Prostatic Duct Urothelial Carcinoma))) 39.20%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39899](http://purl.obolibrary.org/obo/NCIT_C39899) (Secondary Prostate Urothelial Carcinoma))) 39.20%
- [NCIT:C32725](http://purl.obolibrary.org/obo/NCIT_C32725) (Hematopoietic and Lymphoid Cell) and (not ([NCIT:C39897](http://purl.obolibrary.org/obo/NCIT_C39897) (Prostate Ductal Adenocarcinoma, Solid Pattern))) 39.20%


